Neo Medical, a Swiss-based Medtech company developing care solutions for spinal surgery, unveiled the next steps in the US and German strategic markets to support the company's rapid growth.
Since the launch of the first product in Germany in 2017, NEO technologies have been adopted by more than 100 centres in Germany and used in over 10,000 surgeries, with more than 90% surgeries performed by recurrent users. As another step to further establish the company's leading position in this high growth market, Neo Medical announced the acquisition of TriOs Medical in Germany. Neo Medical will leverage years of collaboration with TriOs Medical as the company's exclusive German commercial organization to strengthen its position in the +350M€ strategic German thoraco-lumbar fixation market.
Neo Medical also announced the appointment of Jon P. Verbiest to the role of President for the company's operations in the US strategic market. A seasoned professional from the US spine market, Jon worked for 18 years at Synthes Spine and Depuy Synthes before joining K2M, Spine Wave, Silony Medical and H Wave in Director of Sales and Business Development roles in the US. In his new position, Jon will be responsible for further strengthening and scaling Neo Medical commercial activities in the largest Spine market in the world.
Scaling-up in the US
Neo Medical also announced the deployment of a new US-focused organizational structure, with the appointment of new Area Directors to support the company's continued growth in this strategic market for Neo Medical.
(Press release / ES)
Please login or sign up to comment.
Commenting guidelines